Hjem › Kronisk lymfatisk leukæmi › Oregon › Eugene
Kronisk lymfatisk leukæmi kliniske forsøg i Eugene, OR
6 studier for Kronisk lymfatisk leukæmi søger deltagere på steder i og omkring Eugene (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
RekruttererFase 3
- Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
RekruttererFase 3
- Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
RekruttererFase 3
- Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
RekruttererFase 1/2
- Oncology Associates of Oregon, Eugene
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
RekruttererFase 2
- Williamette Valley Cancer Institute & Research Center, Eugene
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
RekruttererFase 3
- Willamette Valley Cancer Institute and Research Center /ID# 266326, Eugene
Kronisk lymfatisk leukæmi forsøg i andre byer
- Boston, MA31 studier
- Columbus, OH28 studier
- Durham, NC27 studier
- Washington, DC22 studier
- Seattle, WA20 studier
- Rochester, MN19 studier
- New York City, NY18 studier
- Houston, TX17 studier
- Baldwin Park, CA16 studier
- Milwaukee, WI15 studier
- Cincinnati, OH14 studier
- Chicago, IL14 studier
Andre studier i Eugene
- Ikke-småcellet lungecancer13 studier
- Ægstockræft9 studier
- Livmoderslimhindekræft8 studier
- Brystkræft7 studier
- Multipelt myelom6 studier
- Metastatisk cancer6 studier
- Kræft (alle typer)6 studier
- Stofbrug og afhængighed5 studier
- Lungecancer5 studier
- Makuladegeneration5 studier
- Overvægt4 studier
- Prostatakræft3 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.